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Abstract
Gay, bisexual, and other men who have sex with men (GBM) are disproportionately affected
by the HIV epidemic. Despite the promise of pre-exposure prophylaxis (PrEP) in reducing
HIV transmission risk, barriers for uptake and persistence exist. We sought to identify
whether GBM in a nationwide cohort who have not yet initiated PrEP (n = 906) would prefer
to get PrEP-related care from a primary care provider (PCP) compared to a specialist clinic
or provider. We then sought to identify their level of interest and factors associated with pref-
erence for using home-based PrEP services (i.e., HB-PrEP), defined to participants as con-
ducting HIV/STI self-testing from home with PrEP prescription mailing after an initial in-
person clinic visit. We examined the associations of demographics, sexual HIV transmission
risk, concern about frequent medical checkups associated with PrEP, health care access,
and PrEP intentions with preferences for healthcare provider type and HB-PrEP. Concern
about frequent medical checkups were associated with preferring a PCP for PrEP-related
care, but men who perceived a barrier to bringing up the topic of PrEP with a doctor pre-
ferred a specialist clinic or provider more than a PCP. HB-PrEP was more appealing for
younger men and those engaged in sexual HIV transmission risk, suggesting HB-PrEP
could help reach GBM most vulnerable to HIV and in need of PrEP. HB-PrEP expansion
has potential to increase PrEP uptake and persistence among GBM, particularly for men
with barriers to clinic-based care and higher intentions to initiate PrEP. Clinical guidelines
regarding HB-PrEP are needed to expand its use.
Introduction
Over 1.2 million people are living with HIV in the United States (US), and over 40,000 new
cases of HIV are diagnosed each year nationally [1]. Gay, bisexual, and other men who have
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sex with men (GBM) are disproportionately affected by HIV, representing 67% of all incident
infections of HIV and 84% of new infections among males in the US during 2015 [1]. New bio-
medical mechanisms of HIV prevention are emerging, including the use of pre-exposure pro-
phylaxis (PrEP). PrEP is currently FDA approved as a once-daily pill (emtricitabine/tenofovir
disoproxil fumarate) to reduce HIV acquisition risk [2], which has shown ability to reduce
HIV seroconversion by up to 92% in clinical trials [3]. The Centers for Disease Control and
Prevention (CDC) estimates that as many as one in four GBM would benefit from the HIV
protection PrEP offers [4], and some researchers have found that this proportion may even be
as high as two-thirds [5].
Uptake of PrEP among GBM has been slow despite increasing awareness of PrEP [6–8].
One US national study of GBM found that 64% met CDC-criteria for PrEP use [5]; however,
only an estimated 1% of the estimated 4.5 million US national GBM who may be good candi-
dates for PrEP are currently prescribed it [5, 9, 10]. The Motivational PrEP Cascade is a contin-
uum used to understand important milestones for PrEP uptake and persistence [5]. In this
cascade, men willing and intending to initiate PrEP must know of and speak to a medical pro-
vider to obtain a PrEP prescription, and those who initiate PrEP require quarterly follow-up
appointments for HIV testing as part of PrEP persistence. Even among those GBM who know
of a potential PrEP provider and are intending to initiate PrEP, over 47% had not spoken to a
medical provider and obtained a PrEP prescription [5].
Research is currently limited as to where GBM want to receive their PrEP-related care. Dis-
comfort in talking to a doctor about PrEP is documented as one potential barrier to initiating
PrEP [11]. Among GBM, awareness of PrEP has been associated with having a healthcare pro-
vider who is aware that they have sex with other men (i.e., “out”), potentially facilitating cultur-
ally competent HIV prevention [12]; however, men who had not discussed their same-sex
sexual behavior with a healthcare provider were less willing to use PrEP [13]. Discussing PrEP
can be difficult for many GBM because of sexual minority stigma [14]. For Black GBM, race-
based distrust in the medical system has been associated with lower willingness to use PrEP
[13], highlighting additional barriers that may be faced by GBM of color–as both racial/ethnic
and sexual minorities–in obtaining a PrEP prescription. Researchers have previously indicated
the importance of structural factors on awareness and intentions to initiate PrEP, but no
known prior research has explicitly asked GBM where and with whom they would prefer to
receive their PrEP related-care.
PrEP use requires maintaining adherence to once-daily dosing and frequent HIV testing,
which create barriers for both PrEP uptake and persistence. PrEP persistence can be defined as
maintaining all aspects of PrEP care, including adequate adherence to medications and obtain-
ing HIV and sexually transmitted infection (STI) testing every three months, as recommended
[15]. Concerns about needing to maintain daily adherence to PrEP have been identified as a
barrier to its use among GBM [16, 17], but research is currently underway to study alternative
mechanisms for dosing, such as on-demand and long-acting injectable PrEP, among others
[18, 19]. Nonetheless, many GBM who have initiated PrEP have reported high adherence;
nearly 98% of men who started PrEP in a US national sample of GBM reported adequate dos-
ing for optimal protection of four or more doses per week [5], and 78–86% of PrEP users had
tenofovir diphosphate drug levels in the highly protective range in demonstration projects
with biologically confirmed testing [20, 21]. Alternative methods of PrEP dosing could reduce
barriers to PrEP uptake for some men who have concerns about once-daily medication adher-
ence [22]. However, research is currently limited on reducing barriers to PrEP uptake associ-
ated with quarterly HIV testing requirements of PrEP use; committing to routine medical
check-up requirements has been identified as a large barrier to PrEP uptake among GBM [16,
17]. Despite high adherence to PrEP in a US national sample of GBM, only 72% of the men on
Home-based PrEP services for gay and bisexual men
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PrEP had returned for quarterly HIV testing [5]. Interventions that address PrEP persistence
issues specifically related to meeting follow-up clinic visit schedules are needed to expand
uptake and maintenance of PrEP use.
Advancements in at-home, self-administered HIV and bacterial STI testing make it feasible
to meet quarterly HIV/STI testing requirements for PrEP use without the necessity of a clinical
visit for each follow-up appointment. HIV self-testing is a highly acceptable method of HIV
testing for GBM [23–27]. Mechanisms of self-collecting oral fluid with samples returned by
mail (e.g., Orasure HIV-1 Oral Fluid Collection Device; Orasure Technologies) [28] can pro-
vide laboratory-based testing services, which has demonstrated antibody reactivity within a
window period less than 30 days after exposure [29]. Moreover, the use of dried blood spot
testing could be integrated as a method of adherence management, which can detect drug lev-
els by testing fingerpick droplets of blood collected on filter paper and transported at ambient
temperature with desiccant [30, 31]. At-home bacterial STI testing–both urethral and rectal–
has also been identified as a feasible testing strategy for GBM [32], and at-home bacterial STI
testing has demonstrated the ability to be a cost-effective alternative to clinic-based testing
[33]. Each of these biomedical advancements could be used as tools for expansion of PrEP per-
sistence management, particularly useful for GBM who want to initiate PrEP but have barriers
to the routine follow-up requirements for facility-based HIV/STI testing.
The purpose of this paper was to study the preferences of GBM who have not yet initiated
PrEP (i.e., PrEP-naïve GBM) to fill critical gaps in the literature. First, we sought to identify
whether PrEP-naïve GBM would prefer to get PrEP-related care from a primary care provider
(PCP) compared to a specialist clinic or provider. We hypothesized men who had health insur-
ance and were “out” to their PCP would prefer to receive PrEP-related care from their PCP
and, conversely, that men without access to an LGBT-friendly provider would prefer to receive
PrEP-related care from someone other than their PCP. Given the frequent nature of medical
visits for PrEP persistence, we hypothesized men with more concern about frequent medical
check-ups would prefer to receive their care from a PCP. Alternatively, we hypothesized men
who had more concern about bringing up the topic of PrEP with a doctor might prefer a spe-
cialist because this provider might not be their regular physician they need to see regularly for
non-PrEP health care. Finally, we hypothesized fewer non-White GBM would prefer a PCP
because of the unique stigma barriers for these men identified in prior research [11, 13, 14],
but we made no other hypotheses about demographic factors and sexual behavior on health-
care provider preferences.
Second, we sought to identify the level of interest and factors associated with preference for
using home-based PrEP services (i.e., HB-PrEP), which we described as using self-adminis-
tered HIV/STI testing from home with prescription mailing after an initial clinical visit for
PrEP prescription. We hypothesized that GBM with less access to applicable health care,
including access to a PCP or LGBT-friendly provider located nearby, would be more likely to
be interested in HB-PrEP. We also anticipated men with more concern about frequent medical
check-ups and more concern about discussing PrEP with a doctor to prefer HB-PrEP. We had
no hypotheses for HB-PrEP preference by demographics or sexual behavior. We present this
paper with both outcomes together because GBM who might be interested in HB-PrEP would
still need to obtain a prescription for PrEP, which would require seeing a primary care or spe-
cialist provider.
Methods
Data used for these analyses were collected as part of the One Thousand Strong study [34], a
national cohort of 1,071 GBM in the US. One Thousand Strong is a longitudinal cohort of
Home-based PrEP services for gay and bisexual men
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HIV-negative (at baseline) GBM prospectively followed over time. Recruitment methods used
targeted sampling to ensure adequate representation of same-sex households based on age,
race/ethnicity, and US geography. Enrolled men had a confirmed HIV-negative test result at
baseline, and cross-sectional data from the 12-month follow-up were used for this analysis.
During the 12-month follow-up assessment in the second half of 2015, participants were asked
about their preferences for receiving PrEP-related care and interest in using home-based PrEP
services (i.e., HB-PrEP). Recruitment and enrollment details are described elsewhere [5, 17,
32, 34–36]. All study procedures were approved by the Institutional Review Board of the City
University of New York.
Of the 1,071 GBM enrolled at baseline, 1,017 (95.0%) completed the 12-month follow-up
assessment. Another eight men were excluded (n = 1,009) because they did not complete the
PrEP questionnaire supplement. As the goal of these analyses was to identify mechanisms to
increase PrEP uptake, men had to self-report HIV-negative (n = 1,005) at the time of the
12-month assessment and not be currently or previously prescribed PrEP. This resulted in a
final analytic sample of 906 HIV-negative, PrEP-naïve GBM.
Measures
Demographics. Demographic data collected from participants included age, race/ethnic-
ity, educational attainment, employment status, income, geographic region of residence deter-
mined from postal codes, and relationship status.
Sexual HIV transmission risk. Participants were asked about their main partners’ HIV-
status, and we also asked participants about behavior indicative of sexual HIV transmission
risk. Men were coded as engaging in sexual HIV transmission risk if they had any condomless
anal sex with an HIV-positive or unknown partner and/or any casual partner in the past three
months.
Structural barriers to PrEP-related care. All men enrolled in this study were tested for
HIV at baseline and again at the 12-month follow-up; therefore, we asked whether men were
tested for HIV only within the last six months (excluding the test performed as part of the
12-month follow-up). Men were also asked if they had health insurance, and we created a cate-
gorized variable to measure primary care provider (PCP) access. Men were categorized as: 1)
not having a PCP, 2) having a PCP, but not reporting being “out” to their PCP, and 3) having a
PCP who is aware that the participant has sex with men (i.e., “out”). Finally, men were asked
whether they had access to an LGBT-friendly healthcare provider that was located within 30
minutes travel time.
PrEP-intentions and PrEP-related care concerns. PrEP intentions were measured by a
single question [5, 17, 35, 36]: “Do you plan to begin PrEP?” Response categories ranged from
1 (no, I definitely will not begin taking PrEP) to 5 (yes, I will definitely begin taking PrEP). PrEP-
related concerns [16, 37] most relevant to structural barriers to care were used for analysis.
Specifically, participants were asked: “[When thinking about whether to take PrEP, how con-
cerned are you about]. . . Having to return for medical check-ups every three months while I
am on PrEP?” and similarly “. . . Having to talk to a doctor about your sex life?” Response cate-
gories ranged from 1 (not at all concerned) to 4 (very concerned).
Preferences for receiving PrEP-related care from a PCP. Participants were asked where
they would prefer to receive their PrEP-related care with the following question: “Suppose that
you were interested in getting a new prescription for PrEP–where would you feel most com-
fortable receiving your PrEP-related medical care and prescriptions?” Men who selected my
primary care provider (my regular doctor) were coded as preferring to receive PrEP-related care
from a PCP, whereas men who answered any of the specialty clinic choices [A clinic specializing
Home-based PrEP services for gay and bisexual men
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in: 1) HIV-related care (e.g., an HIV clinic), 2) Sexual health (e.g., a Planned Parenthood, an
STD clinic), 3) LGBT health care] were coded as preferring specialist clinics and providers.
Men who selected other (i.e., the fifth answer choice; n = 17) were recoded as preferring spe-
cialist clinics and providers, unless their open-text response indicated preference for a PCP or
“all of the above” resulting in recoding as preferring a PCP.
Preference for using HB-PrEP. We asked participants about their preference about using
home-based PrEP services with the following question: “Suppose there was a service where,
after one in-person medical visit, you could then conduct self-administered, HIV/STI testing
from home with a new prescription mailed to you every three months instead of visiting your
medical provider. Which of the following would you prefer?” Response categories were: 1) I
would prefer to use this service, 2) I would prefer to continue visiting a medical provider every
three months, and 3) I have no preference. Participants were coded as preferring HB-PrEP if
they selected the first response, whereas men who preferred continuing to visit their medical
provider or had no preference were coded as not preferring HB-PrEP.
Statistical analyses
Bivariate associations with indications of PrEP-related care preference outcomes were con-
ducted using chi-squared comparisons and logistic regression. All variables that were hypothe-
sized as potential confounders were included in the multivariable models regardless of
statistical significance in bivariate analyses, as bivariate analyses only demonstrate the impact
of the variable on the outcome and not on its potential confounding effect (i.e., on the associa-
tion between a predictor and outcome). For our fully-adjusted regression models, we used
multivariable binary logistic regression calculated separately for: 1) preference receiving PrEP-
related care from a PCP, and 2) preference using HB-PrEP.
Results
Of the 906 HIV-negative, PrEP-naïve men in this study, most were White (72.1%), had a Bach-
elor’s degree or higher education (58.7%), and were employed at least part-time (85.7%).
About half (47.5%) made more than $50,000 in annual income, and average age was 41.9 years
old. Roughly half (53.3%) were in a relationship, and 54 (6.0%) had an HIV-positive main part-
ner. One-third of the sample had engaged in sexual HIV transmission risk in the past three
months, and 41.7% were tested for HIV in the past 6 months between our survey and testing
assessments. Most (90.4%) had health insurance, but a quarter (25.3%) of men did not have a
PCP. Of those with a PCP, 78.6% of them reported that their PCP knew they had sex with
men. Thirty-nine percent of the sample did not report having access to an LGBT-friendly pro-
vider within 30 minutes of travel. On average, intentions to initiate PrEP were modest among
the men in this sample. The average response was just below the threshold of “I might take it,”
and men reported a moderate amount of concerns about PrEP. On average, men were “a little
concerned” about medical check-ups every three months and bringing up the topic of PrEP
with a doctor. See Table 1 for a full description of the sample.
Preference receiving PrEP-related care from a PCP
Over half (57.0%) of the GBM in this sample preferred receiving their PrEP-related care from
a PCP. In bivariate analyses, we found significant differences in preference for receiving PrEP-
related care from a PCP by age, race/ethnicity, income, relationship status, health insurance
status, PCP provider access, access to an LGBT-friendly healthcare provider within 30 minutes
travel time, and concern about bringing up the topic of PrEP with a doctor. All results of bivar-
iate analyses can be found in Table 1. In the multivariable model examining preference for
Home-based PrEP services for gay and bisexual men
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Table 1. Demographics, sexual risk behavior characteristics, health care access, and PrEP-related factors and their associations with 1) prefer-
ence to receive PrEP-related care from a primary care provider and 2) interest in using home-based PrEP services (n = 906).
Prefer Receiving





PrEP Services (Ref: not
preferred)
Categorical Variables n Column % n Row % χ2 n Row % χ2
Race/Ethnicity 12.9** 1.6
Black 70 7.7 37 52.9 50 71.4
Latino 109 12.0 50 45.9 77 70.6
White 653 72.1 395 60.5 470 72.0
Other/Multiracial 74 8.2 34 46.0 58 78.4
Education 0.7 1.2
Less than Bachelor’s degree 374 41.3 207 55.4 263 70.3
Bachelor’s degree or more 532 58.7 309 58.1 392 73.7
Employment 0.0 6.4*
Unemployed 130 14.4 74 56.9 82 63.1
Employed (part-time or full-time) 776 85.7 442 57.0 573 73.8
Income 21.2*** 0.3
Less than $20k per year 131 14.5 63 48.1 97 74.1
$20k to $49k per year 345 38.1 174 50.4 250 72.5
$50k or more per year 430 47.5 279 64.9 308 71.6
Geographic Region 3.5 4.8
Northeast 172 19.0 106 61.6 115 66.9
Midwest 168 18.5 101 60.1 130 77.4
South 318 35.1 174 54.7 229 72.0
West 248 27.4 135 54.4 181 73.0
Relationship Status 5.2* 1.9
Single 423 46.7 224 53.0 315 74.5
In relationship 483 53.3 292 60.5 340 70.4
Main Partner HIV-Status 2.2 2.5
HIV-negative, unknown, or no main partner 852 94.0 480 56.3 621 72.9
HIV-positive 54 6.0 36 66.7 34 63.0
Engaged in Sexual HIV Transmission Risk2 0.7 11.6***
No 604 66.7 350 58.0 415 68.7
Yes 302 33.3 166 55.0 240 79.5
Recent HIV Testing (Within last 6 months) 0.0 0.0
No 528 58.3 300 56.8 383 72.5
Yes 378 41.7 216 57.1 272 72.0
Has Health Insurance Status 12.5*** 0.1
No 87 9.6 34 39.1 64 73.6
Yes 819 90.4 482 58.9 591 72.2
Primary Care Provider (PCP) Access 157.4*** 21.0***
No PCP 229 25.3 72 31.4 188 82.1
Not "out" to PCP 145 16.0 49 33.8 112 77.2
"Out" to PCP 532 58.7 395 74.3 355 66.7
An LGBT-Friendly Healthcare Provider is Located Within 30 Minutes Travel
Time
28.6*** 10.9***
No or don’t know 349 38.5 160 45.9 274 78.5
Yes 557 61.5 356 63.9 381 68.4
(Continued )
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receiving PrEP-related care from a PCP, men of Latino or other/multiracial race/ethnicity had
lower odds of preferring a PCP compared to White men. Although access to a PCP provider
was not significantly associated with PCP preference for PrEP-related care, men with PCPs
who were aware that they have sex with men had significantly higher odds of preferring to
receive their PrEP-related care from a PCP compared to men who were not “out” to their
PCP. Men with higher concern about quarterly medical check-ups every three months had sig-
nificantly higher preference for receiving PrEP-related care from their PCP, but men with
higher concern about bringing up the topic of PrEP with their doctor had significantly lower
odds of preferring a PCP for PrEP-related care. No other variables were significantly associated
with PCP preference for PrEP-related care in the multivariate model (see Table 2 for complete
results).
Preference using HB-PrEP
Most (72.3%) GBM were interested in HB-PrEP. Bivariate analyses are similarly reported in
Table 1. Briefly, we found significant differences in preference for using HB-PrEP by age,
employment status, engagement in sexual HIV transmission risk, PCP provider access, access
to an LGBT-friendly provider within 30 minutes travel time, PrEP intentions, and concerns
about medical checkups every three months and bringing up the topic of PrEP with a doctor.
In multivariable regression, older men had significantly lower odds of preferring HB-PrEP.
Men in the Midwest had significantly higher odds of preferring HB-PrEP compared to men in
the Northeast; 77.4% of men in the Midwest preferred HB-PrEP, but men in the Northeast had
the lowest frequency of preferring HB-PrEP (66.9%). Men who had engaged in sexual HIV
transmission risk had higher odds of preferring HB-PrEP compared to those who had not, and
men with higher intentions to initiate PrEP had higher odds of preferring HB-PrEP. GBM
who did not live within 30 minutes travel time to an LGBT-friendly provider had higher odds
of preferring HB-PrEP compared to men without, as did men who had more concern about
receiving medical check-ups every three months. Other variables tested in our multivariable









PrEP Services (Ref: not
preferred)
Categorical Variables n Column % n Row % χ2 n Row % χ2
Continuous Variables M SD OR SE OR SE
Age 41.9 13.9 1.02*** 0.01 0.98*** 0.01
PrEP Intentions (Range: 1–5) 2.6 1.0 0.90 0.06 1.51*** 0.12
Concern about Medical Checkups Every 3 Months (Range: 1–4) 2.1 1.1 0.93 0.06 1.43*** 0.11
Concern about Bringing up the Topic of PrEP with Doctor (Range: 1–4) 1.8 1.0 0.46*** 0.04 1.58*** 0.14
* p < 0.05.
** p < 0.01.
*** p < 0.001.
1 PCP = primary care provider.
2 Any condomless anal sex with an HIV-positive or unknown partner and/or any casual partner in past 3 months.
Percentages may not add up to 100 because of rounding.
https://doi.org/10.1371/journal.pone.0189794.t001
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Table 2. Results of both fully-adjusted logistic regression models predicting 1) preference to receive PrEP-related care from a primary care pro-
vider and 2) interest in using home-based PrEP services (n = 906).
Prefer Receiving PrEP-Related
Care from a PCP1 (Ref: prefer
specialist clinics and providers)
Prefer using Home-Based PrEP
Services (Ref: not preferred)
Predictor Variables AOR 95% CI AOR† AOR 95% CI AOR†
Age 1.00 0.98–1.01 0.95 0.98** 0.97–0.99 0.76
Race/Ethnicity (Ref: White)
Black 0.79 0.45–1.40 0.94 0.96 0.53–1.75 0.99
Latino 0.56* 0.34–0.91 0.83 0.68 0.42–1.12 0.88
Other/Multiracial 0.55* 0.31–0.97 0.85 0.95 0.51–1.77 0.99
Education (Ref: Less than Bachelor’s degree)
Bachelor’s degree or more 0.97 0.70–1.34 0.99 1.32 0.94–1.85 1.15
Employment (Ref: Unemployed)
Employed (part-time or full-time) 0.86 0.54–1.39 0.95 1.34 0.84–2.13 1.11
Income (Ref: Less than $20k per year)
$20k to $49k per year 1.00 0.61–1.62 1.00 0.96 0.57–1.60 0.98
$50k or more per year 1.33 0.79–2.23 1.15 1.18 0.69–2.01 1.08
Geographic Region (Ref: Northeast)
Midwest 1.04 0.64–1.71 1.02 1.70* 1.02–2.85 1.23
South 0.99 0.64–1.53 0.99 1.18 0.77–1.83 1.08
West 0.93 0.59–1.48 0.97 1.41 0.88–2.24 1.16
Relationship Status (Ref: Single)
In relationship 1.02 0.74–1.43 1.01 1.02 0.72–1.44 1.01
Main Partner HIV-Status (Ref: HIV-negative, unknown, or no main partner)
HIV-positive 0.89 0.45–1.76 0.97 0.65 0.33–1.27 0.90
Engaged in Sexual HIV Transmission Risk2 (Ref: No)
Yes 0.94 0.67–1.31 0.97 1.72** 1.19–2.50 1.29
Recent HIV Testing (Within last 6 months; Ref: No)
Yes 0.89 0.65–1.23 0.95 0.85 0.61–1.20 0.93
PrEP Intentions 1.01 0.86–1.19 1.01 1.44*** 1.21–1.71 1.46
Has Health Insurance Status (Ref: No)
Yes 1.34 0.77–2.32 1.09 1.18 0.66–2.10 1.05
Primary Care Provider (PCP) Access (Ref: Not "out" to PCP)
No PCP 0.75 0.46–1.23 0.88 1.18 0.67–2.09 1.08
"Out" to PCP 3.37*** 2.17–5.25 1.82 0.75 0.46–1.23 0.87
Within 30 Minutes of LGBT-Friendly Provider (Ref: Yes)
No or don’t know 0.89 0.64–1.24 0.95 1.50* 1.05–2.14 1.22
Concern about Medical Checkups Every 3 Months 1.23* 1.05–1.45 1.25 1.35*** 1.14–1.59 1.37
Concern about Bringing up the Topic of PrEP with Doctor 0.51*** 0.42–0.61 0.52 1.20 0.98–1.47 1.20
Model Statistics
F-test (df) F(22, 883) = 234.1*** F(22, 883) = 114.4***
Psuedo R2 0.19 0.11
* p < 0.05.
** p < 0.01.
*** p < 0.001.
1 PCP = primary care provider.
2 Any condomless anal sex with an HIV-positive or unknown partner and/or any casual partner in past 3 months.
† Standardized AOR reported to improve comparability between continuous variables measured using different metrics, as the AOR is based on a one
standard deviation unit change in the variable.
https://doi.org/10.1371/journal.pone.0189794.t002
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Discussion
In our nationwide cohort of GBM who had not yet initiated PrEP, more than half said they
would prefer to receive PrEP-related care from a PCP; however, nearly three-quarters of men
preferred to receive PrEP persistence care via HB-PrEP services. As men who are interested in
receiving HB-PrEP would still need to go to a healthcare provider for their first visit for PrEP
prescription, these data are relevant for both PrEP uptake and persistence among GBM. PCPs
need to be prepared to discuss and prescribe PrEP to GBM, but just under half of GBM prefer
to receive this care from a specialist clinic or provider. In response to the providers’ perspec-
tives, including the “purview paradox” [38] indicating confusion for the best place for patients
to receive PrEP-related care, GBM in this sample indicated interest in care from both PCPs
and specialists.
Despite mixed healthcare provider preferences across the whole sample, the largest deter-
minant of PrEP-related care provider preference was whether the participant was “out” to
their PCP. We found no differences between GBM who were not “out” to their PCP and those
who did not have a PCP on provider preference; thus, having a PCP is only important for pref-
erence if that provider is aware that he engages in same-sex sexual behavior. This finding adds
to an existing body of literature identifying the importance of healthcare providers’ ability to
provide a non-stigmatized environment for discussing sexual behavior with competent care
for GBM [39–42]. This is particularly important because men who worried more about the
quarterly medical checkups currently recommended for PrEP would prefer to engage in the
frequent care with a PCP, yet men who had more concern about bringing up the topic of PrEP
with a doctor preferred to get PrEP-related care from a specialist clinic or provider. Healthcare
providers need to be similarly prepared to provide PrEP-related care; 24% of PCPs had not
heard of PrEP and only 17% had prescribed it in the 10 cities with the highest HIV prevalence
between July 2014 and May 2015 [43], but PCPs desire additional training and resources to
provide competent PrEP-related care [44]. From these findings, appropriate public health mes-
saging interventions should be tailored for PrEP uptake by indicating different options for
GBM to obtain PrEP based on their individual concerns.
Although we found no significant differences between most demographic variables and
provider preferences for PrEP-related care, GBM who were of Latino or other/multiracial
race/ethnicity had significantly lower odds of preferring PrEP-related care from a PCP com-
pared to Whites. Black GBM did not significantly differ from White GBM in our multivariable
analysis of provider preference; however, we did find that about 53% of Black GBM preferred
a PCP compared to over 60% for White GBM. Thus, our lack of significance could be the result
of the limited number of Black GBM in our sample. Nonetheless, these findings conform with
our current knowledge about barriers specific to non-White GBM. Race-based medical mis-
trust, distrust in the pharmaceutical industry, and sexuality stigmas are all barriers to PrEP
uptake for non-White GBM [13, 14], which could be a reason these men prefer a specialist
clinic or provider that can better relate with them than a typical PCP. In bivariate analyses, we
also found GBM with higher income, health insurance, older age, and being partnered more
frequently preferring care from a PCP; however, these plausible predictors of health care access
were not significant after accounting for PCP access in our multivariate model. We found a
similar attenuating effect on the correlation of LGBT-friendly provider access observed in
bivariate analyses after adjusting for PCP access in the multivariate analysis. It is plausible that
men who are “out” to their PCP stated that they had access to an LGBT-friendly provider,
assuming this provider was within 30 minutes travel time as stated in our question.
After initial PrEP prescription, we found that a majority of the GBM in this sample would
prefer using HB-PrEP for PrEP persistence. Both younger men and those who had recently
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engaged in sexual HIV transmission risk preferred HB-PrEP to the general model of PrEP-
care delivery (i.e., returning for quarterly medical care visits for prescription renewal and
HIV/STI testing). This is perhaps the most important finding in our research, as younger
GBM engaging in HIV transmission risk are the most vulnerable population to HIV [1]. Based
on our HB-PrEP findings, it is plausible that younger GBM may also be more inclined to use
other newer technologies for HIV prevention (e.g., HIV self-testing), but further research
exploring these other technologies is needed with younger GBM because of the relatively older
age of our sample; nonetheless, we had sufficient variability in age with enough younger men
to examine the impact of age on our outcomes of interest in this study. Moreover, GBM with
higher intentions to initiate PrEP preferred HB-PrEP more frequently compared to those with
less intentions, indicating we might best reach individuals who want to start PrEP by offering
HB-PrEP. The expansion of HB-PrEP services has the potential to increase PrEP uptake
among younger GBM at highest-HIV risk and those who plan to initiate PrEP; thus, clinical
guidelines for PrEP use should consider providing recommendations for the use of HB-PrEP.
Regarding geographical differences, we found men in the Midwest preferred HB-PrEP
more compared to men in the Northeast. HB-PrEP could resonate most with people who live
greater distances away from a major city–there are more of these men in the Midwest than
Northeast. Despite differences by race/ethnicity in healthcare provider preferences, we found
no differences by race/ethnicity in our analyses with HB-PrEP. Issues of medical and pharma-
ceutical mistrust and stigma could matter most for the initial uptake of PrEP, but have less
impact on the preference of care for PrEP persistence among non-White GBM. However, we
caution minimizing the negative implications of stigma–particularly HIV pill stigma–on PrEP
use because HB-PrEP does not attempt to ameliorate stigma associated with others thinking
the PrEP user is HIV-positive or shame associated with being a PrEP user; both have been
identified in prior literature [37].
The implications of preference for HB-PrEP based on health care access and concerns
about frequent medical checkups has similar relevance to PrEP persistence, in addition to our
aforementioned discussion on uptake. GBM without access to an LGBT-friendly provider
within 30 minutes travel time had higher preference for HB-PrEP, indicating HB-PrEP has the
potential to reduce barriers for continuation of PrEP-related care for those without proximal
access. Limited access to an LGBT-friendly provider could indicate that they reside in an area
with higher structural stigma against same-sex behavior [45]. This barrier could be more pro-
nounced among GBM who live in rural areas where access to these services may be limited,
which is plausible based on prior research that found nearly all (98%) PrEP users resided in
metropolitan areas [46]. Furthermore, GBM with more concern about the quarterly medical
checkups associated with PrEP use had higher preference for HB-PrEP similarly; thus,
HB-PrEP is a mechanism to reduce their perceived barriers to PrEP persistence.
Limitations
The strengths of this study should be understood in light of its limitations. The predominately-
White sample in this study is indicative of the HIV-negative population of GBM in the US;
White men outnumber their Black and Latino counterparts [47], and pre-existing and ongoing
racial disparities in HIV precluded a lot of men of color from joining our study because they
were HIV-positive [34]. Further research with larger samples of non-White GBM are needed
to more fully study these issues given their higher-HIV risk compared to non-White GBM [1].
Second, all data are subject to the limitations associated with self-reported data collection pro-
cedures, for example multiple testing effects and potential response bias, despite our efforts to
reduce demand effects with self-administered surveying. Third, we assessed sexual HIV
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transmission risk based on any condomless anal sex with an HIV-positive or unknown partner
and/or any casual partner in the past three months, but we do not have data on whether the
HIV-positive partner had an undetectable viral load. Fourth, our description of HB-PrEP ser-
vices described receiving prescription mailing and at-home HIV/STI testing after an initial in-
person, clinic-based visit. HB-PrEP in practice might differ after clinical recommendations are
made, such as HB-PrEP offered after an initial clinic-based appointment and a three-month
follow-up for more comprehensive physiological testing (e.g., kidney function). Fifth, the low
pseudo R-squared values, while not a true measure of model uncertainty, provides some initial
indication of unexplained variance; further qualitative research is needed to identify additional
factors that might influence preference for PrEP-related care provider type and HB-PrEP.
Sixth, we excluded men currently or previously on PrEP because of theoretical differences
compared to those who have not yet initiated PrEP. Further research is needed about PrEP-
related care received by current PrEP users, in addition to research on current PrEP-users’
preferences for HB-PrEP. Finally, GBM enrolled in this cohort have participated in at-home
HIV and bacterial STI testing as part of this study at baseline; thus, preferences for HB-PrEP
might differ from those who have not yet engaged in these at-home testing behaviors.
Conclusion
In this US-nationally representative sample of GBM, men had split preferences of where they
would like to receive their PrEP-related care, with being “out” to a PCP the largest determinant
of preferences. Meaningful barriers of concern about frequent medical checkups were associ-
ated with preferring a PCP for PrEP-related care, but men who perceived a barrier to bringing
up the topic of PrEP with a doctor preferred a specialist clinic or provider more than a PCP.
HB-PrEP was more appealing for younger men and those engaged in sexual HIV transmission
risk, suggesting HB-PrEP could help reach GBM most vulnerable to HIV and most in need
of PrEP. The expansion of HB-PrEP has potential to increase PrEP uptake and persistence
among GBM, particularly for men with barriers to clinic-based care and higher intentions to
initiate PrEP. Therefore, we recommend the implementation and evaluation of HB-PrEP to
guide the development of clinical guidelines for its use.
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